The Victoria Mills Limited: Files 113th Annual Report for 2025-26

The Victoria Mills Limited has officially filed its 113th Annual Report for the financial year ended March 31, 2026. The report details the company’s financial results, including a net profit of ₹666.25 Lakhs, and provides an overview of its operations, board activities, and future outlook. Key financial highlights include total income of ₹5562.52 Lakhs and a recommended dividend of 50%.

Victoria Mills Files 113th Annual Report

The Victoria Mills Limited has submitted its 113th Annual Report covering the financial year ended March 31, 2026. This comprehensive report offers shareholders detailed insights into the company’s performance, governance, and strategic direction.

Financial Highlights for FY 2025-26

The report indicates a net profit of ₹666.25 Lakhs for the financial year, a significant increase from the ₹55.43 Lakhs recorded in the previous year. Total income stood at ₹5562.52 Lakhs, compared to ₹3049.52 Lakhs in FY 2024-25. The Directors have proposed a dividend of 50%, subject to shareholder approval at the upcoming Annual General Meeting.

Operational and Governance Overview

The annual report outlines the company’s operational reviews, financial position, and board activities. It also details the composition of the Board of Directors, attendance at meetings, and the functioning of various committees, including the Audit Committee and the Nomination and Remuneration Committee. The report also includes a Secretarial Audit Report and a Certificate on Corporate Governance, affirming the company’s adherence to regulatory requirements.

Outlook and Future Strategy

The Management Discussion Analysis (MDA) section of the report highlights the company’s business focus on developing high-end residential villas in Alibaug. It discusses opportunities and threats, internal control systems, and the company’s commitment to corporate governance and stakeholder responsibility.

Source: BSE

Previous Article

Mankind Pharma: Approves Voluntary Liquidation of Subsidiary Bharat Serums

Next Article

Vijaya Diagnostic Centre: Sets Record Date for Final Dividend & AGM